Advertising Policy
The Journal of Diabetes, Metabolism and Endocrinology is committed to maintaining editorial independence, academic integrity, transparency, and public trust. Advertising and other commercial activities must not influence editorial decisions, peer-review processes, manuscript acceptance, or the scientific content published by the journal.
1. Separation of Advertising and Editorial Content
All advertising activities are kept strictly separate from the journal’s editorial and peer-review functions. Advertisers have no role in decisions regarding manuscript selection, peer review, acceptance, rejection, or publication.
2. Acceptance of Advertisements
The journal may consider advertisements that are relevant to its readership and consistent with the journal’s academic and professional objectives. All advertisements are subject to prior approval by the journal or its authorized representative.
The journal reserves the right to refuse, withdraw, or discontinue any advertisement at its sole discretion.
3. Scientific and Medical Claims
Advertisements must comply with applicable laws, regulations, and accepted standards for medical and scientific communication. Advertisements must not contain misleading, deceptive, unsupported, or exaggerated claims regarding medicines, medical devices, diagnostic products, treatments, supplements, or healthcare services.
4. Independence from Editorial Decisions
Payment for advertising, sponsorship, or other commercial activities does not provide any influence over:
- Editorial decisions
- Manuscript acceptance or rejection
- Peer-review outcomes
- Publication priority
- Editorial content
- Author selection or reviewer selection
Acceptance of an advertisement does not constitute endorsement of the advertised product, service, organization, or company by the journal or its editors.
5. Identification of Advertisements
Advertisements must be clearly distinguishable from editorial and scholarly content. Commercial material will be appropriately identified as advertising, sponsored content, or promotional material, where applicable, to avoid confusion with peer-reviewed content.
6. Conflicts of Interest
Advertisers, sponsors, editors, reviewers, and authors are expected to disclose relevant conflicts of interest where applicable. Commercial relationships must not compromise the integrity or independence of the journal's scholarly activities.
7. Prohibited Advertising
The journal will not knowingly accept advertisements that:
- Promote illegal or fraudulent activities.
- Contain false, misleading, discriminatory, defamatory, or offensive material.
- Make unsupported medical or scientific claims.
- Misrepresent research findings or clinical evidence.
- Conflict with applicable laws, professional standards, or publication-ethics principles.
- Could reasonably damage the integrity or reputation of the journal.
8. Digital Advertising
For advertisements displayed on the journal website or other digital platforms, the journal may determine their placement, format, duration, and presentation. Advertisements must remain visually distinguishable from editorial content and must not interfere with access to scholarly material or the peer-review process.
9. Editorial Oversight
The Editorial Office retains full authority over the acceptance, placement, modification, suspension, or removal of advertisements. Commercial considerations will never override editorial, ethical, or scientific standards.
10. Compliance and Ethical Standards
The journal seeks to conduct its advertising activities consistently with recognized publication-ethics principles, including relevant COPE guidance, while maintaining transparency and editorial independence.
By maintaining a clear separation between advertising and editorial activities, the Journal of Diabetes, Metabolism and Endocrinology aims to ensure that commercial interests never compromise the quality, credibility, or integrity of its published research.
